The selective metabotropic glutamate receptor 5 antagonist mavoglurant (AFQ056) reduces the incidence of reflux episodes in dogs and patients with moderate to severe gastroesophageal reflux disease
| Image |  |
|---|---|
| Description | scientific article published on 23 March 2017 |
| Author/s |
author: Mike Ufer |
| Publication date | March 23, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |